|
1
|
Koo TY and Yang J: Current progress in
ABO-incompatible kidney transplantation. Kidney Res Clin Pract.
34:170–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi K and Saito K: ABO-incompatible
kidney transplantation. Transplant Rev (Orlando). 27:1–8. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takahashi K, Tanabe K, Ooba S, Yagisawa T,
Nakazawa H, Teraoka S, Hayasaka Y, Kawaguchi H, Ito K, Toma H, et
al: Prophylactic use of a new immunosuppressive agent,
deoxyspergualin, in patients with kidney transplantation from
ABO-incompatible or preformed antibody-positive donors. Transplant
Proc. 23:1078–1082. 1991.PubMed/NCBI
|
|
4
|
Muramatsu M, Gonzalez HD, Cacciola R,
Aikawa A, Yaqoob MM and Puliatti C: ABO incompatible renal
transplants: Good or bad? World J Transplant. 4:18–29. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morimoto H, Ide K, Tanaka Y, Ishiyama K,
Ohira M, Tahara H, Akita T, Tanaka J and Ohdan H: Different
sensitivity of rituximab-treatment to B-cells between
ABO-incompatible kidney and liver transplantation. Hum Immunol.
77:456–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee KW, Park JB, Oh DK, Na BG, Choi JY,
Cho WT, Lee SH, Park HJ, Cho D, Huh WS and Kim SJ: Short-term
outcomes of ABO-incompatible living donor kidney transplantation
with uniform protocol: Significance of baseline anti-ABO titer.
Transplant Proc. 48:820–826. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Makroo RN, Nayak S, Chowdhry M, Jasuja S,
Sagar G, Rosamma NL and Thakur UK: Role of therapeutic plasma
exchange in reducing ABO titers in patients undergoing
ABO-incompatible renal transplant. Apollo Medicine. 13:31–36. 2016.
View Article : Google Scholar
|
|
8
|
Snell GI, Davis AK, Menahem S, Kotecha S,
Whitford HM, Levvey BJ, Paraskeva M, Webb A, Westall GW and Walker
RG: ABO incompatible renal transplantation following lung
transplantation. Transpl Immunol. 39:30–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tanabe T, Ishida H, Horita S, Yamaguchi Y,
Toma H and Tanabe K: Decrease of blood type antigenicity over the
long-term after ABO-incompatible kidney transplantation. Transpl
Immunol. 25:1–6. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim J, Kim S, Hwang IS, Choi JR, Lee JG,
Kim YS, Kim MS and Kim HO: Effects of neutralization by soluble ABH
antigens produced by transplanted kidneys from ABO-incompatible
secretor donors. Ann Lab Med. 37:254–260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C and Guo H: Transplantation
pathology. People's Medical Publishing House (edition 1); Beijing,
China: 2009
|
|
12
|
Cao J, Chen C, Gao Y, Hu L, Liang Y and
Xiao J: Identification of a protein associated with the activity of
cytokine-induced killer cells. Oncol Lett. 14:6937–6942.
2017.PubMed/NCBI
|
|
13
|
Cao J, Liu L, Zhang Y, Xiao J and Wang Y:
The influence of HK2 blood group antigen on human B cell activation
for ABOi-KT conditions. BMC Immunol. 18:492017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang J, Kan Q, La n, Zhao X, Zhang Z,
Yang S, Li H, Wang L, Xu L, Cheng Z and Zhang Y: Chemotherapy in
combination with cytokine-induced killer cell transfusion: An
effective therapeutic option for patients with extensive stage
small cell lung cancer. Int Immunopharmacol. 46:170–177. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khalili I, Koch M, Thaiss F, Plaetke R,
Bruegger J and Peine S: Systematic comparison of IgM and IgG ABO
antibody titers by using tube and gel card techniques and its
relevance for ABO-incompatible kidney transplantation. Clin Lab.
63:1393–1401. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan W, Wang F, Guo D, Ke Y, Shen Y, Lv C
and Zhang M: High serum level of haptoglobin is associated with the
response of 12 weeks methotrexate therapy in recent-onset
rheumatoid arthritis patients. Int J Rheum Dis. 19:482–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delanghe JR, Langlois MR and De Buyzere
ML: Haptoglobin polymorphism: A key factor in the proatherogenic
role of B cells? Atherosclerosis. 217:80–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huntoon KM, Russell L, Tracy E, Barbour
KW, Li Q, Shrikant PA, Berger FG, Garrett-Sinha LA and Baumann H: A
unique form of haptoglobin produced by murine hematopoietic cells
supports B-cell survival, differentiation and immune response. Mol
Immunol. 55:345–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Doria-Rose NA, Longo NS, Laub L,
Lin CL, Turk E, Kang BH, Migueles SA, Bailer RT, Mascola JR and
Connors M: Isolation of human monoclonal antibodies from peripheral
blood B cells. Nat Protoc. 8:1907–1915. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Beyer A and Aebersold R: On the
dependency of cellular protein levels on mRNA abundance. Cell.
165:535–550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Letterio JJ: Murine models define the role
of TGF-beta as a master regulator of immune cell function. Cytokine
Growth Factor Rev. 11:81–87. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DiRenzo DM, Chaudhary MA, Shi X, Franco
SR, Zent J, Wang K, Guo LW and Kent KC: A crosstalk between
TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth
muscle cell proliferation. Cell Signal. 28:498–505. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kashiwagi I, Morita R, Schichita T, Komai
K, Saeki K, Matsumoto M, Takeda K, Nomura M, Hayashi A, Kanai T and
Yoshimura A: Smad2 and Smad3 inversely regulate TGF-β autoinduction
in Clostridium butyricum-activated dendritic cells. Immunity.
43:65–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lan HY: Smads as therapeutic targets for
chronic kidney disease. Kidney Res Clin Pract. 31:4–11. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McKarns SC, Letterio JJ and Kaminski NE:
Concentration-dependent bifunctional effect of TGF-beta 1 on
immunoglobulin production: A role for Smad3 in IgA production in
vitro. Int Immunopharmacol. 3:1761–1774. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y and Derynck R: Transcriptional
regulation of the transforming growth factor-beta-inducible mouse
germ line Ig alpha constant region gene by functional cooperation
of Smad, CREB, and AML family members. J Biol Chem.
275:16979–16985. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chacko BM, Qin BY, Tiwari A, Shi G, Lam S,
Hayward LJ, De Caestecker M and Lin K: Structural basis of
heteromeric smad protein assembly in TGF-beta signaling. Mol Cell.
15:813–823. 2004. View Article : Google Scholar : PubMed/NCBI
|
